Management of Hypotension In Preterm Infants: The HIP Trial Protocol for a Randomized Controlled Trial of Hypotension Management in the Extremely Low Gestational Age Newborn
Phase of Trial: Phase III
Latest Information Update: 04 Oct 2019
Price : $35 *
At a glance
- Drugs Dopamine (Primary)
- Indications Hypotension
- Focus Registrational; Therapeutic Use
- Acronyms HIP
- Sponsors BrePco Biopharma
- 30 Sep 2019 Status changed from recruiting to discontinued.
- 25 Jun 2019 According to a BrePco Biopharma media release, this trial is being conducted by a consortium of 13 institutions, mostly university hospitals, from six EU member states and Canada. The HIP trial was funded in part by a European Union FP7 grant.
- 25 Jun 2019 According to a BrePco Biopharma media release, interim results from the trial were reported at the Paediatric Academic Societies annual meeting.